{
    "organizations": [],
    "uuid": "4804e9ac491edd459ca38df42dc14c7f8ca86d89",
    "author": "",
    "url": "https://www.cnbc.com/video/2018/01/12/alder-biopharmaceuticals-ceo-migraine-medicine-closer-to-fda-approval.html",
    "ord_in_thread": 0,
    "title": "Breakthrough treatment for migraines on path to FDA approval, biotech CEO says",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Breakthrough treatment for migraines on path to FDA approval, biotech CEO says 19 Hours Ago Jim Cramer caught up with Alder Biopharmaceuticals co-founder and CEO Randall Shatzman about his company's treatment for severe migraines.",
    "published": "2018-01-13T02:00:00.000+02:00",
    "crawled": "2018-01-13T02:54:54.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "breakthrough",
        "treatment",
        "migraine",
        "path",
        "fda",
        "approval",
        "biotech",
        "ceo",
        "say",
        "hour",
        "ago",
        "jim",
        "cramer",
        "caught",
        "alder",
        "biopharmaceuticals",
        "ceo",
        "randall",
        "shatzman",
        "company",
        "treatment",
        "severe",
        "migraine"
    ]
}